Patents by Inventor Sehwan Yang

Sehwan Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR INCREASING LYMPHOCYTE COUNT BY USING IL-7 FUSION PROTEIN IN TUMORS
    Publication number: 20220305086
    Abstract: A method for increasing a lymphocyte count in a subject in need thereof including administering to the subject (i) a modified interleukin-7 of the following formula (I): A?IL-7 wherein A is an oligopeptide consisting of 1 to 10 amino acid residues, and the IL-7 is a polypeptide which is capable of binding to IL-7 receptor; or (ii) an interleukin-7 fusion protein comprising (a) the modified interleukin-7, (b) a second domain containing an oligopeptide having 1 to 10 amino acid residues consisting of methionine, glycine, or a combination thereof; and (c) a third domain which prolongs the half-life of the interleukin-7 fusion protein.
    Type: Application
    Filed: September 4, 2020
    Publication date: September 29, 2022
    Applicants: GENEXINE, INC., NEOIMMUNE TECH, INC.
    Inventors: Young Chul SUNG, Jung Won WOO, MinK yu HEO, Sang In YANG, SeHwan YANG
  • G-CSF immunoglobulin fusion proteins
    Patent number: 8586048
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: November 19, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation
    Inventors: Sehwan Yang, Young Chul Sung
  • Chimeric immunoglobulin fusion proteins
    Patent number: 8586038
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: November 19, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation of Phohang University of Science and Technology (Postech)
    Inventors: Sehwan Yang, Young Chul Sung
  • Erythropoietin immunoglobulin fusion proteins
    Patent number: 8586531
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: November 19, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation of Phohang University of Science and Technology (Postech)
    Inventors: Sehwan Yang, Young Chul Sung
  • Human growth hormone immunoglobulin fusion proteins
    Patent number: 8529899
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: June 11, 2012
    Date of Patent: September 10, 2013
    Assignees: Genexine, Inc., Postech Academy-Industry Foundation
    Inventors: Sehwan Yang, Young Chul Sung
  • IMMUNOGLOBULIN FUSION PROTEINS
    Publication number: 20120276043
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Application
    Filed: June 11, 2012
    Publication date: November 1, 2012
    Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science & Technology (POSTECH, Genexine Co., Ltd
    Inventors: Sehwan YANG, Young Chul Sung
  • IMMUNOGLOBULIN FUSION PROTEINS
    Publication number: 20120276097
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Application
    Filed: June 11, 2012
    Publication date: November 1, 2012
    Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science and Technology (POSTECH), Genexine Co., Ltd.
    Inventors: Sehwan YANG, Young Chul Sung
  • IMMUNOGLOBULIN FUSION PROTEINS
    Publication number: 20120276096
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Application
    Filed: June 11, 2012
    Publication date: November 1, 2012
    Applicants: POSTECH Academy-Industry Foundation of Pohang University of Science and Technology (POSTECH), Genexine Co., Ltd
    Inventors: Sehwan YANG, Young Chul Sung
  • IMMUNOGLOBULIN FUSION PROTEINS
    Publication number: 20110091416
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Application
    Filed: November 19, 2010
    Publication date: April 21, 2011
    Applicants: Genexine Co., Ltd, POSTECH Academy-Industry Foundation of Pohang University of Science and Technology ( POSTECH)
    Inventors: Sehwan YANG, Young Chul Sung
  • Immunoglobulin fusion proteins
    Patent number: 7867491
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: January 11, 2011
    Assignees: Genexine Co., Ltd., Postech Academy-Industry Foundation of Pohang University of Science and Technology
    Inventors: Sehwan Yang, Young Chul Sung
  • Immunoglobulin Fusion Proteins
    Publication number: 20080300188
    Abstract: Disclosed are fusion proteins comprising a biologically active molecule and an immunoglobulin (Ig) Fc domain which is linked to the biologically active molecule. The Fc domain is a hybrid human Fc domain of (i) IgG1, IgG2 or IgG4 or (ii) IgG4 and IgD. The hybrid Fc is useful as a carrier of biologically active molecules.
    Type: Application
    Filed: May 30, 2008
    Publication date: December 4, 2008
    Applicants: Genexine Co., Ltd, POSTECH Academy-Industry Foundation of Pohang
    Inventors: Sehwan Yang, Young Chul Sung